Silymarin for COPD: A Study on Breathing and Quality of Life
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests whether adding silymarin (a herbal supplement from milk thistle) to your regular COPD treatment can improve your lung function, reduce stress in your body, and help you feel better day-to-day.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of COPD confirmed by a breathing test (FEV1/FVC less than 0.7).
- You are between 40 and 80 years old.
- You have not had a COPD flare-up or been in the hospital for one in the last month.
- You do not have asthma, bronchiectasis, lung scarring, tuberculosis, or lung cancer.
- You do not have diabetes, liver disease, heart disease, kidney stones, kidney disease, hyperparathyroidism, or other cancers.
- You have not used antioxidant supplements like vitamins C, E, or N-acetylcysteine in the last month, and you are not allergic to silymarin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether vitamin C, an antioxidant, can help slow the progression of COPD and improve prognosis. If you qualify, you may take vitamin C and have your lung health monitored over time.
This study tests whether taking a probiotic can improve symptoms, lung function, and inflammation in people with COPD. It is for adults with stable COPD who have not had a flare-up or treatment change in the last two months.
This study looks at the health of Brazilian adults with COPD. It aims to understand how the condition affects people and may help improve future treatments.
This study looks at whether combined heart and lung checks can improve COPD management. If you have COPD and a heart condition, the results may help doctors better tailor your treatment.
This study tests an experimental drug for people with moderate to severe COPD, especially those with chronic bronchitis. It aims to see how the drug affects certain markers in your body and whether it helps with your COPD symptoms.
This study tests whether silymarin (an extract from milk thistle) can help treat ulcerative colitis when added to your usual treatment. It may reduce inflammation and oxidative stress in the colon.
Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.